Forming part of the HCV Action National Hepatitis C ODN Stakeholder Webinar series, this webinar looked at what we know of reinfections and how to prevent them, as well as harm reduction services and their benefits.
Speakers from Public Health England, The Hepatitis C Trust, and NHS England gave talks on how reinfections tie into elimination efforts, and hosted a Q&A session to answer audience questions.
HCV testing in NSP (Needle and Syringe Provision) Community Pharmacies Pilot (Phase 2)
Download
This report from the London Joint Working Group on Substance Use and Hepatitis C (LJWG) shows the findings from a pilot project providing point of care testing for hepatitis C to people who inject drugs accessing needle and syringe programmes based at community pharmacies in London. Of the 66 people who accepted a test, 39% were hepatitis C RNA positive. 78% of those tested also stated they would prefer to receive HCV treatment in their community pharmacy.
